Arimistane

Arimistane is discussed for a drier physique, estrogen-related symptoms and post-cycle therapy (PCT). Reports include a flatter-looking stomach or less breast tenderness, no apparent estrogen change, and aching joints or irritability. Those mixed experiences do not establish reliable estrogen control or recovery after hormone use.

What Arimistane is

• A steroidal compound sold under an estrogen-control label. Arimistane means androsta-3,5-diene-7,17-dione, also written androst-3,5-diene-7,17-dione. It is a non-peptide compound discussed as an aromatase inhibitor, or AI: a blocker of the enzyme that converts androgens into estrogens. That description does not tell us how reliably a marketed oral product changes human hormone levels. Official context Official context
• Arimistane, Arimidex and Aromasin are different identities. Arimidex is anastrozole; Aromasin is exemestane. Their medical evidence and milligram amounts cannot be transferred to Arimistane. PCT means attempts to recover hormone function after suppressive drugs; calling a product PCT does not demonstrate that recovery. Tamoxifen belongs to a different group, selective estrogen-receptor modulators (SERMs). Official context Official context Official context Reddit Official context
• A product containing Arimistane is not an Arimistane-only test. Forum discussions mix standalone tablets or capsules with products such as Arimiplex and PCT V. The whole product, other ingredients and other hormones matter. Brand names and similar chemical spellings are not enough to combine their results. Reddit Reddit

Benefits people report

• A drier appearance is the clearest recurring cosmetic theme. Users describe looking less watery or having a flatter stomach. One says they looked drier without noticing lower estrogen. A change in appearance cannot show whether estrogen, cortisol, fluid balance, diet or another compound caused it. Reddit Reddit
• Less breast tenderness appears in an individual account. A poster described less sensitivity after starting sleep-apnea treatment and alongside diet and training changes. They acknowledged possible placebo and later reported acne. This is not confirmation that breast gland tissue shrank or that hormone function recovered. Personal report

Doses people discuss

These are self-reported milligram amounts in oral-product discussions, not a regimen. Contents were not independently verified; the posts do not establish equivalent absorption across products.

• 25 mg per occasion, four times weekly: 100 mg per week. That is one hormone replacement therapy (HRT) commenter’s report, not 100 mg daily. Another commenter recalled about 50 mg daily but was unsure of the amount. These are separate patterns, not an established usual dose. Reddit
• 50 mg every other day in a separate account. The author described two weeks of use. Every-other-day frequency must stay attached to the number; it is different from 50 mg every day. Personal report
• 75 mg per day in a blend; 200 mg per day in a high outlier. The blend report specifies two capsules containing 37.5 mg each and also names laxogenin. The separate 200 mg account describes four weeks of use; it does not establish a safe upper limit or greater effectiveness. Reddit

Half-life

• 2.17–2.5 hours appears in forum claims, unverified for Arimistane. One post asserts 2.5 hours without a study. Another explicitly borrows a 2.17-hour value from 7-keto-DHEA and guesses that Arimistane is similar. That extrapolation, made by a supplement representative, is not measured human Arimistane clearance. AnabolicMinds AnabolicMinds

Onset: when changes are noticed

• Two weeks is a report checkpoint, not a precise onset. The every-other-day user reported reduced tenderness while two weeks into use, without stating the first day it changed. A different HRT account describes a laboratory change over about six weeks; that is a lab endpoint, not felt onset. Personal report Reddit

Duration: how long a change lasts

• No dependable single-dose benefit duration emerges from these accounts. Appearance and tenderness reports describe repeated use. They do not establish how long one dose works, or how long an effect persists after stopping. A circulated half-life cannot supply those missing answers. Reddit Personal report AnabolicMinds

Cycles and time off

• Four-week use and an eight-week proposal are different evidence. The high-amount appearance account describes four weeks actually used. The older Erase thread proposes eight weeks and then becomes confused about product versions. It does not verify a completed Arimistane course. Reddit AnabolicMinds
• Short interruptions appear, without an established recovery rule. The commenter recalling 50 mg daily described aching joints after a few weeks and stopping for a day or two. That does not establish that hormone levels recovered during the break. No optimal course or time-off interval is established here. Reddit

Good to know

• Joint discomfort, irritability and skin changes belong beside the positive reports. One user described a shorter temper and aching joints; another reported acne. These symptoms cannot by themselves diagnose high or low estradiol, commonly abbreviated E2. Reddit Personal report
• Abnormal lipids in a hormone stack cannot isolate Arimistane’s effect. The recent lipid-thread respondent used prohormones and took unspecified Arimistane amounts on two consecutive days before testing. They reported poor HDL/LDL and estrogen of 6 without a unit. No Arimistane-only comparison or numerical lipid panel was provided. Reddit
• Potential hormone effects involve more than appearance. The FDA’s scientific review highlights bone and reproductive concerns associated with disrupted estrogen signaling and insufficient Arimistane safety information. Evidence about other aromatase inhibitors is relevant context, not a measured Arimistane risk rate. Official context
• A supplement label is not regulatory approval. In its 2018 VMI Sports letter, FDA said Arimistane was not a dietary ingredient and challenged the described product as an unapproved new drug. That marketing finding is separate from controlled-substance scheduling. Official context
• Tested sport: prohibited at all times under WADA S4.1. The 2026 list names Arimistane explicitly. Forum timing estimates do not establish a drug-test clearance window. Official context

What the community accounts reveal

• Low E2 reports and unchanged labs coexist. Cylon357 reported sensitive E2 moving from the mid-30s to 4 during HRT; units were absent. AnabolicMinds user kisaj instead described no change across two lab checks, later noting that E2 was already controlled. Neither account settles potency. Reddit AnabolicMinds
• A positive appearance report may involve another AI. One enthusiastic commenter also used anastrozole and DIM and changed testosterone exposure. Their belief that Arimistane worked through cortisol does not isolate either its benefit or mechanism. Another user’s blend experience included no joint dryness, so adverse effects were not universal in these posts. Reddit
• Estrogen, cortisol and water loss are competing explanations. The dry-look thread contains a first-person cosmetic report alongside arguments over mechanism. One responder clarified that cortisol was only a possibility. Repeating that explanation does not turn it into a hormone measurement. Reddit
• PCT claims and product names can mislead. In the on-cycle/PCT thread, respondents challenge treating an AI as equivalent to a SERM such as tamoxifen. A later Arimiplex commenter reports abnormal liver bloodwork and calls that potency; the report neither isolates Arimistane nor makes harm evidence of benefit. Reddit
• Advice changes, and a promised follow-up is not a result. A forum participant who initially supported Arimistane for estrogen control later advised against relying on it. In the recent lipid thread, a respondent planned later testing while using enclomiphene; the inspected thread does not provide that result. AnabolicMinds Reddit

What formal research adds

• Metabolite detection is different from proving PCT effectiveness. The FDA review describes a small human administration study designed to identify urinary metabolites and says the available evidence was insufficient to evaluate the compound’s full handling in the body. It does not establish a bodybuilding dose, dependable estrogen suppression or a benefit-duration clock. Official context
• A small human study measured urinary markers, not recovery. The 2019 study abstract describes three volunteers receiving a single 25 mg oral dose, with no relevant effect on the measured urinary steroid profile. That endpoint is not a serial blood-estradiol assessment and cannot settle repeated-use claims. The study amount is research context, separate from community doses. Official context
• The 7-keto-DHEA connection does not supply a half-life. A 2021 analytical study concluded that Arimistane detected after 7-oxo-DHEA could arise through degradation rather than metabolic conversion. This challenges the simple metabolite story used in forum extrapolation; it does not measure Arimistane clearance. Official context